Dr. Miyo Yamashita Skip to main content
Dr. Miyo Yamashita named President and Chief Executive Officer of The Princess Margaret Cancer Foundation
Dr. Miyo Yamashita, President and Chief Executive Officer

The Princess Margaret Cancer Foundation is pleased to announce the appointment of Dr. Miyo Yamashita as President and Chief Executive Officer.  

Dr. Yamashita brings over 20 years of agile, inspiring, and innovative leadership to the Foundation, having helped a wide range of organizations inside and outside the health sector scale and grow to meet their potential. Most recently, she held the position of Director, Strategy & Operations for the University of Toronto’s Schwartz Reisman Institute for Technology and Society. 

“Miyo will make an incredible contribution to our Foundation and we are so pleased to have her on board,” said Janice Fukakusa, Board Chair of The Princess Margaret Cancer Foundation. “She accepts the appointment at an exciting time for the Foundation, which has done tremendous work supporting ground-breaking cancer research, education, and clinical care. I want to thank our entire team for their efforts over the past year, with special thanks to our Chief Operating Officer Meaghan Stovel McKnight, who has ensured that we have not missed a beat. Cancer has not stopped, so neither have we.” 

Dr. Yamashita was selected through an extensive recruitment process led by Egon Zehnder, a leading global consultancy for executive search efforts.  

Dr. Yamashita has held various leadership roles in healthcare, banking, and technology. She spent six years at Deloitte Canada, where she held the position of Managing Partner, Talent & Workplace and Chief Transformation Officer. In 2017, the Women’s Executive Network recognized her as one of Canada’s Top 100 Most Powerful Women. 

“I am thrilled to join the team at The Princess Margaret Cancer Foundation,” said Miyo Yamashita, incoming President and Chief Executive Officer. “Like so many Canadians, I have seen the toll that cancer can take on individuals and families, including my own, and am proud to be part of a movement to conquer cancer in our lifetime. With the right people, vision, and growth strategy, I believe that the Foundation can have exponential impact in the years ahead, and I’m excited to return to the UHN family and hit the ground running.” 

Throughout the past year, the Foundation has achieved its highest ever gross revenue and met all commitments to Princess Margaret Cancer Centre, despite the suspension of most in-person events. Dr. Yamashita’s ability to dream big and plan strategically will help the Foundation as it prepares for a landmark campaign.

Together, we can Conquer Cancer In Our Lifetime